HIV-1 gp120 and Modified Vaccinia Virus Ankara (MVA) gp140 Boost Immunogens Increase Immunogenicity of a DNA/MVA HIV-1 Vaccine.
about
Vaccine Induction of Heterologous Tier 2 HIV-1 Neutralizing Antibodies in Animal Models.Neutralization tiers of HIV-1.Immunogenicity of NYVAC prime-protein boost HIV-1 envelope vaccination and SHIV challenge of nonhuman primates.Uninfected Bystander Cells Impact the Measurement of HIV-Specific Antibody-Dependent Cellular Cytotoxicity Responses.Development of a Stable MGAT1 CHO Cell Line to Produce Clade C gp120 With Improved Binding to Broadly Neutralizing Antibodies
P2860
HIV-1 gp120 and Modified Vaccinia Virus Ankara (MVA) gp140 Boost Immunogens Increase Immunogenicity of a DNA/MVA HIV-1 Vaccine.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
HIV-1 gp120 and Modified Vacci ...... ty of a DNA/MVA HIV-1 Vaccine.
@en
type
label
HIV-1 gp120 and Modified Vacci ...... ty of a DNA/MVA HIV-1 Vaccine.
@en
prefLabel
HIV-1 gp120 and Modified Vacci ...... ty of a DNA/MVA HIV-1 Vaccine.
@en
P2093
P2860
P50
P356
P1433
P1476
HIV-1 gp120 and Modified Vacci ...... ty of a DNA/MVA HIV-1 Vaccine.
@en
P2093
Celia LaBranche
David Beaumont
Georgia D Tomaras
Harriet L Robinson
Kelly E Seaton
Linda S Wyatt
Nicole L Yates
Rahul Basu
S Munir Alam
Sheetal Sawant
P2860
P356
10.1128/JVI.01077-17
P407
P577
2017-10-11T00:00:00Z